Loading...
Acute flare of Bullous Pemphigus with Pembrolizumab used for treatment of metastatic urothelial cancer.
In the past decade, the resurgence of immunotherapy has changed the landscape of cancer therapy. Check point inhibitors targeting CTLA4 (Cytotoxic T-lymphocyte antigen-4), PD-1 (programmed death1) on lymphocytes and PD-L1 (programmed death ligand1) on tumors cells are currently utilized in the manag...
Na minha lista:
| Udgivet i: | J Immunother |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6339565/ https://ncbi.nlm.nih.gov/pubmed/29111983 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CJI.0000000000000191 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|